HEATNCT07226310
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
At risk: Primary completion moved at least 9 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Dec 2026 to Oct 2027
- Eligibility criteria expanded, about 10 words
- Start date changed from estimate of Sep 2026 to Aug 12, 2026
- Secondary endpoints: details revised at 1 of 1 entry
- Notable Start date: May 2026 to Sep 2026v5
- Notable Start date: Mar 2026 to May 2026v4
- Minor Start date: Feb 2026 to Mar 2026
- Study description shortened, about 70 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Dec 2025 to Feb 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Post-HSG Pain Questionnaire
Timeframe: Measured 1 hour after HSG procedure
Secondary (1)
Rate of unilateral and bilateral proximal fallopian tube occlusion
Arms and interventions
Cold HSGNo intervention
HSG contrast will be standard, room-temperature
Warm HSGActive comparator
HSG constrast will be warmed.
Drugs: Warmed HSG
Sites
1 site in 1 country
- University of Oklahoma Health CenterOklahoma City, Oklahoma, United States